Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Publicado: |
Elsevier
2019
|
| Sumario: |
|---|